India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
Eli Lilly’s obesity drug shows up to 30% weight loss in trialEli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This onc...
Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-SeptemberRPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company a...
Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
Govt cracks down on GLP-1 drugs: Safety first amid weight-loss hypeIndia's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are now prescriptio...
Not heart, nor liver: Doctor reveals the one organ that determines your longevityThe pancreas, not the heart or lungs, is key to aging, regulating metabolism and energy. Irregular eating patterns and prolonged stress ove...
Wegovy edges closer to PBS listing in Australia for high-risk obesity patientsA key Australian health committee has recommended Wegovy for subsidized access. This drug targets adults with existing heart conditions and...
The Good Bug launches ‘natural’ weight loss solution amid GLP-1 drug debateThe startup claims that, unlike injectable drugs such as Ozempic and Mounjaro, which can have side effects, its solution is a non-invasive ...
Mumbai doctor bombarded with weight-loss drug Mounjaro enquires. Don't ignore his adviceDr. Rahul Baxi highlights that a new Rs 16,000-a-month weight-loss injection isn't a miracle solution without essential lifestyle changes. ...
Biocon launches diabetes, obesity management drug in UKBiocon has launched Liraglutide, a drug for diabetes and obesity management, in the UK under the brand names Liraglutide Biocon and Biolide...
Mounjaro: Here's all about the wonder antidiabetic medicine touted as the 'most powerful' weight-loss drugMounjaro is making headlines recently. This antidiabetic injectable drug has been touted as the most powerful weight-loss drug available. I...
Almonds can help cut calories, finds studyResearchers, who studied how almonds can alter human appetite, discovered that a snack of 30-50 grammes of almonds could encourage people t...
- Coffee can reduce diabetes risk
Bengaluru, Oct 20 (IANS) The medicine that can delay your diabetes is right on your coffee table.
3D printing has a solution for Type 1 diabetesThe new 'bioplotting' technique is showing promise as a means of better treating hypoglycemia.